Vertex Pharmaceuticals (VRTX) Equity Ratio (2009 - 2026)

Vertex Pharmaceuticals' Equity Ratio history runs 18 years deep, the most recent figure standing at 0.73 for Q1 2026.

• In Q1 2026, Equity Ratio rose 1.4% year-over-year to 0.73; the TTM figure through Mar 2026 stood at 0.73 (up 1.4% YoY), while the FY2025 annual figure was 0.73, changed 0.05% from the prior year.
• Equity Ratio was 0.73 for Q1 2026 at Vertex Pharmaceuticals, roughly flat from 0.73 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.78 in Q3 2022 to a low of 0.7 in Q3 2025.
• Historically, Equity Ratio has averaged 0.74 across 5 years, with a median of 0.76 in 2023.
• The sharpest annual moves came in 2022 and 2024: Equity Ratio grew 3.26% in 2022, then dropped 7.53% in 2024.
• A 5-year view of Equity Ratio shows it stood at 0.77 in 2022, then climbed by 0.9% to 0.77 in 2023, then dropped by 5.84% to 0.73 in 2024, then fell by 0.05% to 0.73 in 2025, then gained by 0.43% to 0.73 in 2026.
• The last three Equity Ratio figures came in at 0.73 (Q1 2026), 0.73 (Q4 2025), and 0.7 (Q3 2025), per Business Quant data.